Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T20:32:42.097Z.
Calculation as of: 2026-10-06T20:32:42.097Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 673a23962afa1f964289f2c5c8e96f6ae4ccf5481b64718d91ae2e5553a82c87
EARNINGS YIELD
N/A
Market Cap
$172.42M
Earnings Yield
N/A
TTM Avg
4.56%
3Y Avg
2.71%
5Y Avg
6.34%
Market Cap
$171.13M
Earnings Yield
N/A
TTM Avg
12.15%
3Y Avg
12.15%
5Y Avg
12.15%
Market Cap
$169.53M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$179.26M
Earnings Yield
93.84%
TTM Avg
50.31%
3Y Avg
28.59%
5Y Avg
28.59%
Market Cap
$179.75M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProQR Therapeutics N.V. (PRQR) | $173.76M | N/A | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | N/A | N/A | N/A | N/A |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | N/A | 4.56% | 2.71% | 6.34% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | N/A | 12.15% | 12.15% | 12.15% |
| Journey Medical Corporation (DERM)vs › | $169.53M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $168.92M | N/A | 15.95% | 15.95% | 15.95% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | 93.84% | 50.31% | 28.59% | 28.59% |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | N/A | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
